Loading...

ADC Therapeutics SA (NYSE:ADCT)

8.07 USD +0.1 USD ( +1.25% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

Profitability Summary

ADC Therapeutics SA's profitability score is 27/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score
27/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Revenue
ADC Therapeutics SA
80.4M
Growth Rates
1 Year
N/A
3 Years
N/A
5 Years
N/A
Operating Income
ADC Therapeutics SA
-231.4M
Growth Rates
1 Year
6%
3 Years
N/A
5 Years
N/A
Net Income
ADC Therapeutics SA
-195.2M
Growth Rates
1 Year
23%
3 Years
N/A
5 Years
N/A

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Gross Margin
ADC Therapeutics SA
98%
Operating Margin
ADC Therapeutics SA
-288%
Net Margin
ADC Therapeutics SA
-243%

ADCT Earnings Waterfall
ADC Therapeutics SA

Revenue
80.4M USD
Cost of Revenue
-1.9M USD
Gross Profit
78.5M USD
Operating Expenses
-309.9M USD
Operating Income
-231.4M USD
Other Expenses
36.3M USD
Net Income
-195.2M USD

Margins Comparison
ADC Therapeutics SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CH
ADC Therapeutics SA
NYSE:ADCT
620M USD
98%
-288%
-243%
IN
Biocon Ltd
NSE:BIOCON
377B INR
67%
13%
8%
US
Abbvie Inc
NYSE:ABBV
249B USD
71%
33%
22%
JP
Takara Bio Inc
TSE:4974
243B JPY
73%
43%
29%
JP
PeptiDream Inc
TSE:4587
193B JPY
72%
35%
28%
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
155B CNY
46%
37%
31%
Country CH
Market Cap 620M USD
Gross Margin
98%
Operating Margin
-288%
Net Margin
-243%
Country IN
Market Cap 377B INR
Gross Margin
67%
Operating Margin
13%
Net Margin
8%
Country US
Market Cap 249B USD
Gross Margin
71%
Operating Margin
33%
Net Margin
22%
Country JP
Market Cap 243B JPY
Gross Margin
73%
Operating Margin
43%
Net Margin
29%
Country JP
Market Cap 193B JPY
Gross Margin
72%
Operating Margin
35%
Net Margin
28%
Country CN
Market Cap 155B CNY
Gross Margin
46%
Operating Margin
37%
Net Margin
31%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

ROE
ADC Therapeutics SA
-85%
ROA
ADC Therapeutics SA
-37%
ROCE
ADC Therapeutics SA
-50%
ROIC
ADC Therapeutics SA
-206%

Return on Capital Comparison
ADC Therapeutics SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
ADC Therapeutics SA
NYSE:ADCT
620M USD
-85%
-37%
-50%
-206%
IN
Biocon Ltd
NSE:BIOCON
377B INR
9%
4%
7%
6%
US
Abbvie Inc
NYSE:ABBV
249B USD
93%
9%
17%
13%
JP
Takara Bio Inc
TSE:4974
243B JPY
23%
19%
33%
28%
JP
PeptiDream Inc
TSE:4587
193B JPY
10%
6%
9%
9%
CN
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
155B CNY
78%
46%
90%
66%
Country CH
Market Cap 620M USD
ROE
-85%
ROA
-37%
ROCE
-50%
ROIC
-206%
Country IN
Market Cap 377B INR
ROE
9%
ROA
4%
ROCE
7%
ROIC
6%
Country US
Market Cap 249B USD
ROE
93%
ROA
9%
ROCE
17%
ROIC
13%
Country JP
Market Cap 243B JPY
ROE
23%
ROA
19%
ROCE
33%
ROIC
28%
Country JP
Market Cap 193B JPY
ROE
10%
ROA
6%
ROCE
9%
ROIC
9%
Country CN
Market Cap 155B CNY
ROE
78%
ROA
46%
ROCE
90%
ROIC
66%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Operating Cash Flow
ADC Therapeutics SA
-212.1M
Growth Rates
1 Year
5%
3 Years
N/A
5 Years
N/A
Capital Expenditures
ADC Therapeutics SA
-6.8M
Growth Rates
1 Year
97%
3 Years
N/A
5 Years
N/A
Free Cash Flow
ADC Therapeutics SA
-218.9M
Growth Rates
1 Year
4%
3 Years
N/A
5 Years
N/A

See Also

Similar Stocks
Time Machine